Benveniste Ronald, Germano Isabelle M
Department of Neurosurgery, Mount Sinai School of Medicine and Medical Center, New York, New York 10029, USA.
Neurosurg Focus. 2003 Feb 15;14(2):e5. doi: 10.3171/foc.2003.14.2.6.
Frameless image-guided stereotaxy is often used in the resection of high-grade gliomas. The authors of several studies, however, have suggested that brain shift may occur intraoperatively and result in inaccurate resection. To determine the usefulness of frameless stereotactic image-guided surgery of high-grade gliomas, the authors correlated factors predictive of brain shift, such as tumor size, periventricular location, and patient age (as an indicator of brain atrophy) with the extent of resection.
Inclusion criteria included the following: 1) stereotactic volumetric craniotomy for resection of tumor; 2) histologically proven high-grade glioma; 3) preoperative magnetic resonance (MR) imaging demonstration of an enhancing portion of tumor; 4) postoperative MR imaging within 48 hours to assess the extent of resection; and 5) preoperative intention to perform gross-total resection of the enhancing tumor. Fifty-four patients met these criteria between September 1997 and November 2002. Accurate resection was considered to be indicated by a lack of nodular enhancement on postoperative Gd-enhanced MR images obtained within 48 hours of surgery. Frameless stereotactic image-guided surgery resulted in the successful resection of 46 (85%) of 54 high-grade gliomas. Accurate resection was significantly more likely with tumors less than 30 ml in volume than with those greater than 30 ml (93 and 58%, respectively [p < 0.05]). In addition, small periventricular tumors were associated with significant less successful resection compared with nonperiventricular tumor (77 and 96%, respectively [p = 0.5]). Patient age did not affect the likelihood of successful resection.
Frameless image-guided stereotactic techniques can be reliably used for accurate resection of high-grade gliomas when the tumor is less than 30 ml in volume and not adjacent to the ventricular system. In cases involving tumors larger in volume or located near the ventricles, intraoperative ultrasonography or MR imaging updates should be considered.
无框架影像引导立体定向技术常用于高级别胶质瘤的切除。然而,多项研究的作者指出,术中可能发生脑移位,导致切除不准确。为确定无框架立体定向影像引导手术在高级别胶质瘤治疗中的实用性,作者将预测脑移位的因素,如肿瘤大小、脑室周围位置和患者年龄(作为脑萎缩的指标)与切除范围进行了关联分析。
纳入标准如下:1)立体定向体积性开颅肿瘤切除术;2)组织学证实为高级别胶质瘤;3)术前磁共振(MR)成像显示肿瘤强化部分;4)术后48小时内进行MR成像以评估切除范围;5)术前打算对强化肿瘤进行全切。1997年9月至2002年11月期间,54例患者符合这些标准。手术48小时内获得的术后钆增强MR图像上无结节状强化被视为切除准确。无框架立体定向影像引导手术成功切除了54例高级别胶质瘤中的46例(85%)。体积小于30 ml的肿瘤比大于30 ml的肿瘤更有可能实现准确切除(分别为93%和58% [p < 0.05])。此外,与非脑室周围肿瘤相比,脑室周围小肿瘤的成功切除率明显较低(分别为77%和96% [p = 0.5])。患者年龄不影响成功切除的可能性。
当肿瘤体积小于30 ml且不邻近脑室系统时,无框架影像引导立体定向技术可可靠地用于高级别胶质瘤的准确切除。对于体积较大或位于脑室附近的肿瘤,应考虑术中超声或MR成像更新。